Aurothioglucose
Clinical data | |
---|---|
Synonyms | Gold thioglucose, Solganal, Auromyose |
Routes of administration | intramuscular injection |
ATC code | |
Pharmacokinetic data | |
Bioavailability | 0% |
Identifiers | |
| |
CAS Number | |
PubChem CID | |
E number | {{#property:P628}} |
ECHA InfoCard | {{#property:P2566}}Lua error in Module:EditAtWikidata at line 36: attempt to index field 'wikibase' (a nil value). |
Chemical and physical data | |
Formula | C6H11AuO5S |
Molar mass | 392.181 g/mol |
WikiDoc Resources for Aurothioglucose |
Articles |
---|
Most recent articles on Aurothioglucose Most cited articles on Aurothioglucose |
Media |
Powerpoint slides on Aurothioglucose |
Evidence Based Medicine |
Clinical Trials |
Ongoing Trials on Aurothioglucose at Clinical Trials.gov Trial results on Aurothioglucose Clinical Trials on Aurothioglucose at Google
|
Guidelines / Policies / Govt |
US National Guidelines Clearinghouse on Aurothioglucose NICE Guidance on Aurothioglucose
|
Books |
News |
Commentary |
Definitions |
Patient Resources / Community |
Patient resources on Aurothioglucose Discussion groups on Aurothioglucose Patient Handouts on Aurothioglucose Directions to Hospitals Treating Aurothioglucose Risk calculators and risk factors for Aurothioglucose
|
Healthcare Provider Resources |
Causes & Risk Factors for Aurothioglucose |
Continuing Medical Education (CME) |
International |
|
Business |
Experimental / Informatics |
Overview
Aurothioglucose, also known as gold thioglucose, is a chemical compound with the formula AuSC6H11O5. This derivative of the sugar glucose is used to treat rheumatoid arthritis.
History
Throughout history, gold was used to cure diseases, although the efficacy was not established. In 1935, gold drugs were reported to be effective for the treatment rheumatoid arthritis.[1] Although many patients reacted positively to the drug, gold thioglucose was not uniformly effective.
Two gold drugs remain in active clinical use for this purpose in the United States: sodium aurothiomalate (gold sodium thiomalate) and Aurothioglucose, sold under the trade names Myochrysine and Solgonal, respectively. In the United Kingdom, only sodium aurothiomalate and auranofin are used.
Medicinal chemistry
Gold thioglucose features gold in the oxidation state of +I, like other gold thiolates. It is a water-soluble, non-ionic species that is assumed to exist as a polymer.[1] Under physiological conditions, an oxidation-reduction reaction leads to the formation of metallic gold and sulfinic acid derivative of thioglucose.
- 2 AuSTg → 2 Au + TgSSTg
- TgSSTg + H2O → TgSOH + TgSH
- 2 TgSOH → TgSO2H + TgSH
- Overall: 2 H2O + 4 AuSTg → 4 Au + TgSO2H + 3 TgSH
(where AuSTg = gold thioglucose, TgSSTg = thioglucose disulfide, TgSO2H = sulfinic acid derivative of thioglucose)
Preparation
Gold thioglucose can be prepared by treating gold bromide with thioglucose solution saturated with sulfur dioxide. Gold thioglucose is precipitated with methanol and recrystallized with water and methanol.
Miscellaneous observations
In recent research, it has found that injection of gold thioglucose in the mouse induces obesity.[2] Aurothioglucose has an interaction with the antimalarial medication Hydroxychloroquine.
See also
References
- ↑ 1.0 1.1 Shaw, III, C. F. (1999). "Gold-Based Therapeutic Agents". Chemical Reviews. 99: 2589–600. doi:10.1021/cr980431o.
- ↑ Naruta E, Buko V (2001). "Hypolipidemic effect of pantothenic acid derivatives in mice with hypothalamic obesity induced by aurothioglucose". Exp Toxicol Pathol. 53 (5): 393–8. PMID 11817109.
External links
- Pages with script errors
- CS1 maint: Multiple names: authors list
- E number from Wikidata
- ECHA InfoCard ID from Wikidata
- Chemical articles with unknown parameter in Infobox drug
- Articles without EBI source
- Chemical pages without ChemSpiderID
- Chemical pages without DrugBank identifier
- Articles without KEGG source
- Articles without InChI source
- Articles without UNII source
- Drugs with no legal status
- Articles containing unverified chemical infoboxes
- Gold compounds
- IARC Group 3 carcinogens
- Coordination compounds
- Immunosuppressive agents